Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF Prophylaxis for HBV Reactivation in Cancer Patients
NCT04619082Phase 4Active, not recruiting
- Sponsor
- Ditmanson Medical Foundation Chiayi Christian Hospital
- Start
- Jul 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in hepatitis B (HBV), sponsored by Ditmanson Medical Foundation Chiayi Christian Hospital. Started Jul 2021; status: active, not recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04619082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04619082.